(Q35573256)

8 August 2017

1 reference

title

Activation of nuclear receptors by prostaglandins (English)

1 reference

8 August 2017

Tomomi Ide

1

1 reference

8 August 2017

Karine Egan

series ordinal

2

1 reference

8 August 2017

L. Chastine Bell-Parikh

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592554

27 March 2024

Garret A. FitzGerald

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14592554

27 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592554

27 March 2024

publication date

1 June 2003

1 reference

8 August 2017

15 June 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14592554

full work available at URL

27 March 2024

https://api.elsevier.com/content/article/PII:S0049384803004183?httpAccept=text/xml

1 reference

10.1016/S0049-3848(03)00418-3

DOI

https://api.crossref.org/works/10.1016/S0049-3848(03)00418-3

https://api.elsevier.com/content/article/PII:S0049384803004183?httpAccept=text/plain

27 March 2024

1 reference

10.1016/S0049-3848(03)00418-3

DOI

https://api.crossref.org/works/10.1016/S0049-3848(03)00418-3

27 March 2024

1 reference

8 August 2017

volume

110

1 reference

8 August 2017

issue

5-6

1 reference

8 August 2017

page(s)

311-315

1 reference

Genetic and pharmacological analysis of prostanoid receptor function

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Prostaglandin D2 as a mediator of allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Regulatory role of cyclic adenosine 3′,5′-monophosphate on the plattelet cyclooxygenase and platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Phosphorylation of the thromboxane receptor alpha, the predominant isoform expressed in human platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Identification of the platelet ADP receptor targeted by antithrombotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Prostaglandin endoperoxide synthase: structure and catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

The binding of arachidonic acid in the cyclooxygenase active site of mouse prostaglandin endoperoxide synthase-2 (COX-2). A putative L-shaped binding conformation utilizing the top channel region

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Coupling between cyclooxygenase, terminal prostanoid synthase, and phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Subcellular localization of prostaglandin endoperoxide H synthases-1 and -2 by immunoelectron microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

The PPARalpha-leukotriene B4 pathway to inflammation control.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

A novel pathway of prostacyclin signaling-hanging out with nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta(delta)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Thioredoxin as a molecular target of cyclopentenone prostaglandins.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Contribution of cyclopentenone prostaglandins to the resolution of inflammation through the potentiation of apoptosis in activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Inducible cyclooxygenase may have anti-inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

Prostaglandins and leukotrienes: advances in eicosanoid biology

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900418-3

7 January 2021

10.1016/S0049-3848(03)00418-3

Identifiers

DOI

1 reference

8 August 2017

1 reference